Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.53% | -2.68% | -15.39% | -4.07% | -5.09% |
| Total Depreciation and Amortization | -13.55% | 4.62% | 0.31% | 0.02% | -4.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -79.93% |
| Total Other Non-Cash Items | -99.10% | 57.62% | -29.22% | 196.05% | 2,123.17% |
| Change in Net Operating Assets | -39.88% | 88.98% | 47.24% | -49.84% | 55.10% |
| Cash from Operations | -22,418.75% | 100.22% | -50.82% | -53.97% | 39.98% |
| Capital Expenditure | 72.07% | 21.49% | -142.55% | 38.16% | 84.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 72.07% | 21.49% | -142.55% | 38.16% | 84.62% |
| Total Debt Issued | 95.38% | -70.76% | 63.38% | -19.28% | -65.27% |
| Total Debt Repaid | 29.94% | -183.33% | 24.15% | 73.50% | 82.18% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 218.48% | -84.46% | 74.23% | 8.14% | -33.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.26% | 1,583.58% | 89.69% | -198.04% | 322.48% |
